management of local anaesthesia in endodontics halton-peel dental association andrew moncarz bsc,...

87
Management of Local Anaesthesia in Endodontics Halton-Peel Dental Association Andrew Moncarz BSc, DDS, Dip. An, MSc, FRCD(C) March 22, 2007

Upload: jodie-lyons

Post on 24-Dec-2015

217 views

Category:

Documents


0 download

TRANSCRIPT

Management of Local Anaesthesia in Endodontics

Management of Local Anaesthesia in Endodontics

Halton-Peel Dental AssociationAndrew Moncarz

BSc, DDS, Dip. An, MSc, FRCD(C)

March 22, 2007

Halton-Peel Dental AssociationAndrew Moncarz

BSc, DDS, Dip. An, MSc, FRCD(C)

March 22, 2007

Objectives

Review of: Reported rates of profound anaesthesia Anatomical variations Maximum doses of local anaesthetics Pulpal inflammation as a complicating

factor Adjunctive strategies for profound

mandibular LA

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

What about experienced operators?

Effectiveness of Conventional IANB as

measured by EPT

 

Childers et al. 1997

lido 2% 1:100K

63%

Clark et al. 1999lido 2% 1:100K

73%

Dunbar et al. 1996

lido 2% 1:100K

43%

Guglielmo et al. 1999

mepiv 2% 1:20K

80%

Reitz et al. 1998lido 2% 1:100K

71%

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

Always use a long 25 gauge needle (the red one) 2 reasons:

1. Less deflection 2. Less false negative aspiration

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

Ultrasound Guidance Hannan et al. 1999: Repeated-measures design 40 subjects injected twice at separate

appointments—once with landmarks, once with ultrasound guidance

EPT after profound lip numbness reported Anaesthetic success 38%-92%, no

difference between the techniques Conclusion: accuracy of needle placement

is not the primary reason for failure of IANB

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

Nerve to mylohyoid

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

Berns et al. 1962: injected radiopaque material into pterygomandibular space

Spread is unpredictable Suggestion: inject more LA

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

Decrease in the pH locally Can influence the amount of LA

available in the lipophilic form to diffuse across the nerve membrane

Result is less drug interference of sodium channels

Less likely to influence mandibular block anaesthesia

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

Pulpal Inflammation

Causes activation and sensitization of peripheral nociceptors

Causes sprouting of nerve terminals in the pulp

Causes expression of different sodium channels: TTX-resistant class of sodium channels are 4 times as resistant to blockade by lidocaine and their expression is doubled in the presence of PGE2

Effectiveness of Conventional IANB: Irreversible Pulpitis

Reisman et al.1997

1.8 mL lido 2% 1:100K epi

25%

Nusstein et al. 1998

1.8 mL lido 2% 1:100K epi

19%

Cohen et al. 2000

1.8 mL lido 2%1:100K epi

50%

Claffey et al. 2004

1.8 mL lido 2% 1:100K epi 23%

100% lip anaesthesia

Adjunctive Strategies

Additional Anaesthetic PDL Injection Intraosseous Injection Intrapulpal Injection Different anaesthetic

Retest using the CC

Adjunctive Strategies

Additional Anaesthetic Higher injection Gow Gates Akinosi Nerve to mylohyoid

PDL Injection Intraosseous Injection Intrapulpal Injection Different anaesthetic

Maximum Doses LA

% means g/dL Example:

1% = 1 g/dL 1% = 10g/L 1% = 10 mg/mL

Therefore: 2% = 20 mg/mL

Maximum Doses LA

A cartridge contains 1.8 mL Therefore a cartridge of 2% local

anaesthetic contains 20 mg/mL X 1.8 mL = 36 mg of local anaesthetic

Maximum Doses LA

How much LA can you give? 193 lb 33 yo male Lidocaine 2% 1:100K Articaine 4% 1:200K

2.2 lbs = 1 kg 193 lbs = 88 kg

Maximum Doses LA

Lidocaine 2% Max dose = 7

mg/kg 7mg/kg X 88=616

mg 36 mg/1.8 mL 616mg/36mg/

cart.= 17 cartridges **

Articaine 4% Max dose 7 mg/kg 7 X 88 = 616 mg 72 mg/1.8mL 616 mg/72 mg/cart.

= 9 cartridges

Maximum Doses Epi

% = 1/100 = g/dL Therefore:

1/100 = 1% = 1g/dL = 10 mg/mL 1/1000 = 0.1% = 0.1 g/dL = 1 mg/mL 1/10000 = 0.01% = 0.01 g/dL = 0.1 mg/mL 1/100000 = 0.001% = 0.001 g/dL = 0.01mg/mL

A cartridge contains 1.8 mL Therefore a cartridge of 1:100 000 epi

contains 0.01 mg/mL X 1.8 mL = 0.018 mg(or about 0.02 mg)

Maximum Doses Epi

Cardiovascular patient 0.04 mg Healthy patient 0.2 mg

Maximum Doses LA Lidocaine 2% Max dose = 7 mg/kg 7mg/kg X 88=616

mg 36 mg/1.8 mL 616mg/36mg/cart.= 17 cartridges ** 10-11 cartridges (epi)

Articaine 4% Max dose 7 mg/kg 7 X 88 = 616 mg 72 mg/1.8mL 616 mg/72 mg/cart.

= 9 cartridges

Pregnant Patients

Which Local Anaesthetic to use?

Articaine 4% 1:200 000 epi Lidocaine 2% 1:100 000 epi Mepivacaine 2% 1:20 000 levo Mepivacaine 3% plain

FDA categories (based on risk of fetal injury)

A: controlled studies in humans—no risk to fetus demonstrated

B: animal studies show no risk, no human studies; or animal studies have shown a risk but human studies have shown no risk

C: animal studies show risk, no human studies; or no animal or human studies

Pregnant Patients

Which Local Anaesthetic to use?

Articaine 4% 1:200 000 FDA category C Lidocaine 2% 1:100 000 FDA category B Mepivacaine 2% 1:20 000 FDA

category C Mepivacaine 3% plain FDA category C

Advantages of Injecting “Higher”

Failure to achieve profound local anaesthesia attributed to being “too low” and “too far forward”

Injecting superiorly and more distally may block accessory innervation

3 nodes of Ranvier may not be true

Gow-Gates Technique

Landmarks: Corner of the mouth (contralateral side) Tragus of the ear Disto palatal cusp of the maxillary

second molar AIMING FOR THE NECK OF THE CONDYLE

Efficacy of the Gow-Gates Technique

Author Year GG (%) IANB (%)

Watson and Gow-Gates

1976 98.4 85.4

Gow-Gates and Watson

1977 96.2 85.5

Levy 1981 96 65

Malamed 1981 97.5

Montagnese et al. 1984 35 38

Akinosi Technique

Closed-mouth technique Does not rely on a hard-tissue

landmark Parallel to occlusal plane, height of

the mucogingival junction Advanced until hub is level with distal

surface of maxillary second molar Delayed onset of anaesthesia

Akinosi Technique

Martinez Gonzalez et al. 2003 Pain to puncture less with Akinosi Onset slower 17.8% failure vs. 10.7% IAB/LB

BUT-incomplete LB considered failure

Cruz et al. 1994 Gow Gates more effective, but Akinosi

most acceptable to patients

Nerve to Mylohyoid

Deposit ¼ cartridge of LA on lingual surface of tooth in alveolar mucosa

Goal is to bathe the nerve as branches of it enter the lingual surface of the mandible

Adjunctive Strategies

Additional Anaesthetic PDL Injection Intraosseous Injection Intrapulpal Injection Different anaesthetic

PDL Injection

Technique: needle inserted into the gingival sulcus

at a 30 degree angle towards the tooth bevel placed towards bone advanced until resistance felt anaesthetic injected with continuous

force for about 15 seconds. approx. 0.2 mL of solution 25 vs. 30 gauge needle

PDL Injection

Conventional vs. specific PDL syringes:  Malamed (1982):

similar rates of success D’Souza et al (1987):

no sig. difference in anaesthesia achieved. using the pressure syringe resulted in more

spread of anaesthetic to adjacent teeth  

PDL Injection: Primary Technique

Melamed 1982: 86% overall Faulkner 1983: 81% overall White 1988: variable, short duration

esp. md. molars Walton 1990: “In reviewing the clinical

and experimental literature…the periodontal ligament injection does not meet all of the necessary requirements for a primary technique.”

PDL Injection: Supplemental Technique

Walton and Abbott 1981: Inadequate pulpal anaesthesia following

IAB 92% overall included situations where multiple PDL

injections required most critical factor was to inject under

strong resistance Smith, Walton, Abbott 1983:

83% overall with high pressure syringe

PDL Injection: Anaesthetic Distribution

Garfunkel et al 1983, Smith and Walton 1983, Tagger et al 1994, Tagger et al 1994* spread along path of least resistance influenced by anatomical structures and

fascial planes through marrow spaces avoided PDL route appears to be a form of intraosseous

injection

PDL Injection: Effects on the Periodontium

Animal histological studies Most studies: no long term evidence

of tissue disruption or inflammation Roahen and Marshall 1990: evidence

of localized external resorption

Adjunctive Strategies

Additional Anaesthetic PDL Injection Intraosseous Injection Intrapulpal Injection Different anaesthetic

Intraosseous Injection

Technique for mandibular infiltration Perforate the cortical plate to

introduce LA in medullary bone Bathes the periradicular region in LA 2 commercial systems available:

Stabident (Patterson) X-Tip (Tulsa Dentsply)

Stabident

Stabident

Stabident

Stabident

X-Tip

Success of Conventional IANB + IO as Measured by

EPT

Dunbar et al.

2% lido 1:100K 90%

Gallatin et al.

3% mepivacaine plain

100%

Guglielmo et al.

2% lido 1:100K 100%

Reitz et al. 2% lido 1:100K 94%

IANB + IO in Cases of Irreversible Pulpitis

Nusstein et al. 1998

Lido 2% 1:100K

91%

Parente et al. 1998

Lido 2% 1:100K

79%/ 91%

Reisman et al. 1997

Mepivacaine 3% plain

80%/ 98%

Nusstein et al. 2003

Lido 2% 1:100K

82% (X-Tip)

Bigby et al. 2006

Articaine 4% 1:100K

86%

Adjunctive Strategies

Additional Block (higher injection) PDL Injection Intraosseous Injection Intrapulpal Injection Different anaesthetic

Intrapulpal Anaesthesia

VanGheluwe and Walton 1997: under back-pressure, efficacy of

LA=saline injection Conclusion: back-pressure is the key

to intrapulpal anaesthetic success

Adjunctive Strategies

Additional Anaesthetic PDL Injection Intraosseous Injection Intrapulpal Injection Different anaesthetic

Articaine

Reputation for improved local anaesthetic effect—short linear molecule

Amide local, contains a thiophene ring instead of a benzene ring

Partial hydrolysis by plasma esterases 4% solution—concern with toxicity Potential for methemoglobinemia (like

prilocaine)

Articaine

More effective than other local anaesthetics?

No difference found: Haas et al. 1990 (vs. prilocaine) Vahatalo et al. 1993 (vs. lidocaine) Malamed et al. 2000 (vs. lidocaine) Donaldson et al. 2000 (vs. prilocaine) Claffey et al. 2004 (vs. lidocaine) Mikesell et al. 2005 (vs. lidocaine)

Articaine

Claffey et al. 2004: Articaine vs. lidocaine IANB for

irreversible pulpitis of mandibular teeth Articaine 9/37 (24%) Lidocaine 8/35 (23%) (all subjects had subjective lip

anaesthesia)

Articaine

Paraesthesia? Haas and Lennon 1995: higher incidence

of paraesthesia associated with prilocaine and articaine. Attributed to the higher concentration of drug required for comparable clinical effect

14/11 000 000 injections Statistically higher Clinical relevance? Claffey et al 2004

“clinically rare event”

Articaine

Paraesthesia? Dower 2003 (Dentistry Today) Review article Paraesthesia rates up to 2-4% when

using articaine for lingual blocks or IANBs

RCDSO Dispatch Summer 2005 pg. 26

“Until more research is done, it is the College’s view that prudent practitioners may wish to consider the scientific literature before determining whether to use 4% local anaesthetic solutions for mandibular block injections.”

College Registrar RepliesDispatch Fall 2005 vol. 19,

#4

“This college received legal advice from our general counsel, and from outside counsel, before publishing what we did…The advice we received was that it was certainly within our obligation to advise members to be aware of the literature…”

Articaine

Hillerup and Jensen 2006: Danish population—all cases in Denmark

referred to authors for evaluation 54 injection injuries in 52 patients 54% of all nerve injuries associated with

articaine Substantial increase in number of

injection injuries following introduction of articaine to Danish market in 2000.

Articaine

What about a mandibular infiltration? Recommended by Steve Buchanan Kanaa et al. 2006

Cross-over design comparing articaine and lidocaine for mandibular infiltration for first molars

Anaesthesia measured by maximal EPT X2 Lidocaine 38% effective Articaine 65% effective

Reported Reasons for Mandibular Anaesthesia

Failure

1. Operator Inexperience2. Armamentarium: Deflection of the needle

tip3. Patient factors:

1. Variations in anatomy2. Accessory innervation3. Unpredictable spread of LA4. Local infection5. Pulpal inflammation6. Psychological issues

Kleinknect and Bernstein 1978: positive correlation between anxiety and reported pain during dental treatment

Topical Anaesthetic Benzocaine or

Lidocaine Effectiveness?

Gill and Orr 1979: 15 second application no more effective than placebo

Stern and Giddon 1975: 2-3 minutes=profound soft tissue anaesthesia

Topical Anaesthetic

Recommendations: Dry mucous membranes first 2-3 minutes, but concern with tissue

sloughing Tip of the tongue

Topical Anaesthetic

Benzocaine Spray RCDSO Dispatch 21, 1, Feb/Mar 2007

pp.28-29 Advice to Dentists Benzocaine Sprays and

Methemoglobinemia (MHb) Health Canada—9 suspected cases, none

fatal

Topical Anaesthetic

Benzocaine spray/Methemoglobinemia Recommendations:

Avoid in patients with a history of MHb Consider lidocaine as an alternative Broken/inflamed tissue may promote uptake Use only amount deemed necessary If suspicious, send patient to hospital for

methylene blue tx O2 won’t help, but give it anyways

Methemoglobinemia

Fe2+ ion of the heme group of the hemoglobin molecule is oxidized to Fe3+

Hemoglobin converted to methemoglobin, a non-oxygen binding form of hemoglobin that binds a water molecule instead of oxygen.

Conclusions:

1. Consider topical anaesthetic 2. Re-test using patient’s chief complaint 2. Inject again

Higher More Local Anaesthetic Nerve to Mylohyoid

3. Consider PDL/Intraosseous Anaesthesia 4. Consider Intrapulpal Anaesthesia 5. If they say it hurts, it hurts

Thank you

Questions? Please feel free to contact me:

416-223-1771 [email protected] www.endoasleep.ca